List of ContributorsrnPrefacernSection I. Biology of Blood Vessels and Mechanisms of Vascular Inflammationrn1 Vascular DevelopmentnDomenico Ribatti and Enrico Crivellatorn2 Vascular RepairnChristian Troidl, Kerstin Troidl, Georg Jung, Thomas Schmitz-Rixen and Wolfgang Schaperrn3 Leukocyte TraffickingnBraedon McDonald and Paul Kubesrn4 Dendritic Cells and Vascular InflammationnCornelia M. Weyandrn5 T Cells and Vascular InflammationnJörg J. Goronzyrn6 Autoantibodies and Vascular InflammationnA.Rutgers, J.S.F. Sanders, J.W. Cohen Tervaert, C.G.M. Kallenbergrn7 Neutrophils and Vascular InflammationnMatthew David Morgan and Caroline OS Savagern8 Cytokines and Vascular InflammationnMaria C Cid, Marc Corbera-Bellalta, Ester Planas-Rigol, Ester Lozano, Georgina Espígol-Frigolé, Ana García-Martínez, José Hernández-Rodríguez, Marta Segarrarn9 Oxidative Stress and Vascular InflammationnDavid G. Harrisonrn10 Hemostasis and Vascular InflammationnLawrence Leung and John Morserrn11 Animal Models of VasculitisnMasato Nosern12 Arteries, Smooth Muscle Cells, and Genetic Causes of Thoracic Aortic AneurysmsnAmy J. Reid and Dianna M. Milewiczrn13 Innate Immunity in AtherosclerosisnShuang Chen, Prediman K. Shah and Moshe Arditirn14 Adaptive Immunity in AtherosclerosisnJan NilssonrnSection II. Primary Autoimmune Vascular Diseasesrn15 Historical Perspectives VasculitisnEric L. Mattesonrn16 Approach to the Differential Diagnosis of VasculitisnEamonn S. Molloy and Carol A. Langfordrn17 Imaging of medium and large vessels (CT/PET/MR)nThorsten Alexander Bleyrn18 Kawasaki diseasenRae S.M. Yeungrn19 Henoch-Schonlein PurpuranPhilip J. Hashkes and Alexandra Villa-Fortern20 Polyarteritis NodosanEli M. Miloslavsky and John H. Stonern21 Microscopic polyangiitisnCoen Stegemanrn22 Granulomatosis with Polyangiitis (Wegener's Granulomatosis)nGary S. Hoffman, Carol A. Langford and Ulrich Specksrn23 Churg-Strauss Syndrome (Eosinophilic Granulomatosis with Polyangiitis, EGPA)nChristian Pagnoux and Loïc Guillevinrn24 Giant cell arteritisnCornelia M. Weyand and Jörg J. Goronzyrn25 Takayasu's arteritisnKathleen Maksimowicz-McKinnon and Gary S. Hoffmanrn26 Behçet's SyndromenYusuf Yazici, Ismail Simsek and Hasan Yazicirn27 Cogan's SyndromenRex M. McCallum and E. William St. Clairrn28 Idiopathic cryoglobulinemic vasculitidesnBenjamin Terrier and Patrice Cacoubrn29 Primary central nervous system vasculitisnRula A. Hajj-Ali and Leonard H. Calabresern30 Single organ vasculitisnJosé Hernández-Rodríguez and Gary S. Hoffmanrn31 Primary cutaneous vasculitisnJeffrey P. Callenrn32 Buerger's disease (thromboangiitis obliterans)nAhmet Ruchan Akar and M. Serkan DurdurnSection III. Secondary Causes of Vasculitisrn33 Virus-associated vasculitidesnDimitrios Vassilopoulos and Leonard H. Calabresern34 Drug-induced vasculitisnPeter A. Merkelrn35 Rheumatoid vasculitisnKimberly P. Liang, Carl Turesson, Larry W. Morelandrn36 Vasculopathy/Vasculitis and progressive systemic sclerosisnNezam Altorok, Omar R. Kahaly and Bashar Kahalehrn37 Vasculitis and Sjögren's syndromenGeorge E. Fragoulis and Haralampos M. Moutsopoulosrn38 Vasculitis in systemic lupus erythematosusnRicardo Garcia and Andras Perlrn39 Vasculitis in the Idiopathic Inflammatory MyopathiesnFrederick W. Miller and Chester V. Oddisrn40 Vasculitis and relapsing polychondritisnTanaz A. Kermani and Kenneth J. Warringtonrn41 Systemic Vasculitis in SarcoidosisnAlexandra Villa-Forte and Gary S. Hoffmanrn42 Vasculitis as a Paraneoplastic Syndrome and Direct Tumour Invasion of VesselsnClaire E. Barber and Simon CaretternSection IV. Recognizing Risks and Treating Damage from Vasculitisrn43 Cholesterol and Modifications of Cholesterol in Rheumatic DisordersnJan Willem Cohen Tervaertrn44 Prevention and treatment of medical complicationsnAtul Khasnis and Carol A. Langfordrn45 Ophthalmic Risks and Complications Aassociated with the Treatment of Systemic VasculitisnSteven Yeh and James T. Rosenbaumrn46 Subglottic Stenosis of Granulomatosis with Polyangiitis (Wegener's Granulomatosis)nRahul Seth and Daniel S. Alamrn47 Sino-Nasal Manifestations of Granulomatosis with Polyangiitis (Wegener's Granulomatosis)nDaniel S. Alam, Rahul Seth, Raj Sindwanirn48 Neurologic Damage of VasculitisnC. David Linrn49 Endstage Renal Disease and VasculitisnKirsten de Groot and Charles Puseyrn50 Cardiothoracic Surgery for Takayasu's Arteritis and Giant Cell ArteritisnTurki Albacker and Lars Svenssonrn51 Peripheral Vascular Surgery for Takayasu's Arteritis and Giant Cell ArteritisnRavi R. Rajani and Vikram S. KashyaprnIndex
In recent years, considerable progress has been made in understanding the vasculitic diseases, largely due to the introduction of effective treatments for diseases that were once uniformly fatal, the conduct of structured clinical studies, and advances in immunology and molecular biology. Despite these achievements, the vasculitic diseases continue to be associated with morbidity and mortality from chronic organ damage, relapses, and the side effects of treatment. Investigations into the mechanisms of vascular inflammation may lead to a better comprehension of the pathogenesis of vasculitic diseases and to treatment that is more effective and less toxic. These areas of promising research, together with current knowledge about the vasculitic diseases, are extensively examined in this new edition, which is designed to provide a comprehensive overview of the science and clinical consequences of vascular inflammation in health and disease.